Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-07 Sale | 2024-03-11 7:05 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 65,012 | $21.02 | $1,366,552 | 162,311 (Indirect Direct) | View |
2024-03-04 Sale | 2024-03-06 5:37 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 18,324 | $21.34 | $391,056 | 227,323 (Indirect Direct) | View |
2024-03-01 Sale | 2024-03-05 4:34 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 1,189 | $22.03 | $26,194 | 178,864 (Direct) | View |
2024-03-01 Sale | 2024-03-05 4:31 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 18,844 | $21.77 | $410,234 | 127,109 (Direct) | View |
2024-02-28 Sale | 2024-03-01 6:26 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 14,785 | $21.57 | $318,881 | 23,691 (Direct) | View |
2024-02-27 Sale | 2024-02-29 4:26 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 10,156 | $21.03 | $213,581 | 145,953 (Direct) | View |
2024-01-03 Sale | 2024-01-04 4:30 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 12,000 | $20 | $240,000 | 15,632 (Direct) | View |
2024-01-02 Sale | 2024-01-04 4:30 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 16,670 | $19.17 | $319,564 | 21,019 (Direct) | View |
2023-12-19 Sale | 2023-12-21 4:26 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 9,316 | $19.13 | $178,215 | 37,689 (Direct) | View |
2023-12-07 Sale | 2023-12-11 4:20 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 28,600 | $17.65 | $504,758 | 156,109 (Direct) | View |
2023-09-05 Sale | 2023-09-06 7:03 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 400 | $17.53 | $7,012 | 241,121 (Direct) | View |
2023-07-25 Sale | 2023-07-27 4:30 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 29,000 | $19.14 | $555,160 | 182,127 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Exercise | 2024-03-05 4:34 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 656 | $0 | 178,864 (Direct) | View |
2024-03-01 Exercise | 2024-03-05 4:34 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 656 | $1.59 | 178,864 (Direct) | View |
2024-03-01 Exercise | 2024-03-05 4:31 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 18,844 | $1.86 | 127,109 (Direct) | View |
2024-03-01 Exercise | 2024-03-05 4:31 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 18,844 | $0 | 127,109 (Direct) | View |
2024-01-15 Option Award | 2024-03-01 6:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 583 | $12.35 | 23,691 (Direct) | View |
2024-02-28 Exercise | 2024-03-01 6:26 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 14,785 | $0 | 23,691 (Direct) | View |
2024-02-28 Exercise | 2024-03-01 6:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 10,771 | $8.83 | 23,691 (Direct) | View |
2024-03-01 Exercise | 2024-03-01 6:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 4,014 | $13.88 | 23,691 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 10,156 | $1.86 | 145,953 (Direct) | View |
2024-02-27 Exercise | 2024-02-29 4:26 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 10,156 | $0 | 145,953 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:30 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 12,000 | $0 | 15,632 (Direct) | View |
2024-01-03 Exercise | 2024-01-04 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 12,000 | $8.83 | 15,632 (Direct) | View |
2024-01-02 Exercise | 2024-01-04 4:30 pm | N/A 2028-08-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 16,670 | $0 | 21,019 (Direct) | View |
2024-01-02 Exercise | 2024-01-04 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 16,670 | $13.88 | 21,019 (Direct) | View |
2023-12-19 Exercise | 2023-12-21 4:26 pm | N/A 2028-08-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 9,316 | $0 | 37,689 (Direct) | View |
2023-12-19 Exercise | 2023-12-21 4:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 9,316 | $13.88 | 37,689 (Direct) | View |
2023-12-07 Exercise | 2023-12-11 4:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 28,600 | $1.86 | 156,109 (Direct) | View |
2023-12-07 Exercise | 2023-12-11 4:20 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 28,600 | $0 | 156,109 (Direct) | View |
2023-11-03 Option Award | 2023-11-07 4:33 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 2,777 | $0 | 10,554 (Direct) | View |
2023-11-03 Exercise | 2023-11-07 4:33 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 2,777 | $0 | 10,554 (Direct) | View |
2023-10-04 Exercise | 2023-10-06 4:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 175 | $0 | 17,355 (Direct) | View |
2023-10-04 Tax Withholding | 2023-10-06 4:26 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 52 | $16.01 | 17,355 (Direct) | View |
2023-07-15 Option Award | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 581 | $12.35 | 60,917 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 4,707 | $0 | 60,917 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 30,689 | $0 | 60,917 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 1,383 | $17.76 | 60,917 (Direct) | View |
2023-07-15 Option Award | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 292 | $12.35 | 68,952 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 3,471 | $0 | 68,952 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 45,113 | $0 | 68,952 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,896 | $17.76 | 68,952 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 16,561 | $0 | 470,185 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 181,425 | $0 | 470,185 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 6,619 | $17.76 | 470,185 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 4,556 | $0 | 76,486 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:06 pm | N/A 2033-08-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 49,050 | $0 | 76,486 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,338 | $17.76 | 76,486 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 4,691 | $0 | 185,121 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 49,635 | $0 | 185,121 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 1,378 | $17.76 | 185,121 (Direct) | View |
2023-09-05 Exercise | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 400 | $1.86 | 241,121 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 4,623 | $0 | 241,121 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 45,470 | $0 | 241,121 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 1,241 | $17.76 | 241,121 (Direct) | View |
2023-07-25 Exercise | 2023-07-27 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 29,000 | $1.86 | 182,127 (Direct) | View |
2023-07-25 Exercise | 2023-07-27 4:30 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 29,000 | $0 | 182,127 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 5,000 | $0 | 76,967 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 5:37 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 113,690 | $0 | 2,853,967 (Indirect) | View |
2023-06-06 Option Award | 2023-06-08 4:23 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:22 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:22 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:21 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:20 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:19 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-04-26 Tax Withholding | 2023-04-28 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 291 | $11.15 | 14,395 (Direct) | View |
2023-04-26 Exercise | 2023-04-28 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 990 | $0 | 14,395 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 1,155 | $10.71 | 24,774 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 3,933 | $0 | 24,774 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,353 | $10.71 | 19,984 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,477 | $0 | 19,984 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 734 | $10.71 | 49,402 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 2,498 | $0 | 49,402 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:05 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 2,933 | $10.71 | 265,680 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:05 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 9,992 | $0 | 265,680 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 791 | $10.71 | 19,797 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 2,695 | $0 | 19,797 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 801 | $10.71 | 128,245 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 2,727 | $0 | 128,245 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 45,470 | $0 | 45,470 (Direct) | View |